EG24413A - Compound which inhibit the release of inflammatory cytokines - Google Patents

Compound which inhibit the release of inflammatory cytokines

Info

Publication number
EG24413A
EG24413A EG2002091039A EG2002091039A EG24413A EG 24413 A EG24413 A EG 24413A EG 2002091039 A EG2002091039 A EG 2002091039A EG 2002091039 A EG2002091039 A EG 2002091039A EG 24413 A EG24413 A EG 24413A
Authority
EG
Egypt
Prior art keywords
inhibit
release
compound
inflammatory cytokines
cytokines
Prior art date
Application number
EG2002091039A
Other languages
English (en)
Inventor
Michael P Clark
Matthew J Laufersweiler
Jane F Djung
Biswanath De
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of EG24413A publication Critical patent/EG24413A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/20Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
EG2002091039A 2001-09-20 2002-09-21 Compound which inhibit the release of inflammatory cytokines EG24413A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32362501P 2001-09-20 2001-09-20

Publications (1)

Publication Number Publication Date
EG24413A true EG24413A (en) 2009-05-25

Family

ID=23259997

Family Applications (2)

Application Number Title Priority Date Filing Date
EG2002091039A EG24413A (en) 2001-09-20 2002-09-21 Compound which inhibit the release of inflammatory cytokines
EG2002091037A EG24363A (en) 2001-09-20 2002-09-21 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokiness

Family Applications After (1)

Application Number Title Priority Date Filing Date
EG2002091037A EG24363A (en) 2001-09-20 2002-09-21 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokiness

Country Status (32)

Country Link
US (2) US6821971B2 (pt)
EP (3) EP1427727B1 (pt)
JP (3) JP2005504082A (pt)
KR (4) KR20060036125A (pt)
CN (3) CN1257905C (pt)
AR (3) AR037145A1 (pt)
AT (3) ATE287887T1 (pt)
AU (2) AU2002327690B2 (pt)
BR (3) BR0212716A (pt)
CA (3) CA2461071A1 (pt)
CO (3) CO5560590A2 (pt)
CY (1) CY1106398T1 (pt)
CZ (3) CZ2004361A3 (pt)
DE (3) DE60213108T2 (pt)
DK (2) DK1427732T3 (pt)
EG (2) EG24413A (pt)
ES (3) ES2282459T3 (pt)
HU (3) HUP0402378A3 (pt)
IL (3) IL160682A0 (pt)
MA (3) MA27064A1 (pt)
MX (3) MXPA04002569A (pt)
MY (2) MY129329A (pt)
NO (2) NO20041594L (pt)
NZ (3) NZ531123A (pt)
PE (3) PE20030474A1 (pt)
PL (3) PL370362A1 (pt)
PT (3) PT1427727E (pt)
RU (3) RU2278864C2 (pt)
SA (1) SA03230529B1 (pt)
SK (3) SK1502004A3 (pt)
WO (3) WO2003024973A1 (pt)
ZA (3) ZA200401260B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849627B2 (en) 2001-09-20 2005-02-01 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US7087615B2 (en) 2001-09-20 2006-08-08 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which provide analgesia
US7473695B2 (en) * 2001-10-22 2009-01-06 Mitsubishi Tanabe Pharma Corporation 4-imidazolin-2-one compounds
US6677337B2 (en) * 2002-03-19 2004-01-13 The Procter & Gamble Company 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines
PL379544A1 (pl) * 2002-09-09 2006-10-02 Amgen Inc. 1,4,5-podstawione pochodne 1,2-dihydro-pirazol-3-onu i 3-alkoksy 1H-pirazolu jako środki obniżające poziom TNF-alfa oraz interleukin do leczenia stanów zapalnych
WO2004087696A1 (de) * 2003-04-03 2004-10-14 Merck Patent Gmbh Pirazolidin-1,2-dicarbonsaüre-1-((phenyl)-amid)-2-((phenyl)-amid) derivate als koagulationsfaktor xa inhibitoren zur behandlung von thrombosen
GB0308466D0 (en) * 2003-04-11 2003-05-21 Novartis Ag Organic compounds
US7482356B2 (en) * 2003-11-10 2009-01-27 The Procter & Gamble Company Bicyclic pyrazolone cytokine inhibitors
EP2012778A4 (en) * 2006-04-18 2011-08-10 Abbott Lab VANILLOID RECEPTOR (VR1) SUBType 1 ANTAGONISTS AND USES THEREOF
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
MX2011012343A (es) * 2009-05-19 2011-12-14 Dow Agrosciences Llc Compuestos y metodos para controlar hongos.
WO2016205284A1 (en) 2015-06-15 2016-12-22 Cummins Inc. Combustion chamber elasticity device
US20190060286A1 (en) 2016-02-29 2019-02-28 University Of Florida Research Foundation, Incorpo Chemotherapeutic Methods
CN107033090B (zh) * 2017-05-16 2019-05-07 无锡捷化医药科技有限公司 一种1,2,3,4-四氢噌啉的制备方法
RU2721684C1 (ru) * 2019-09-06 2020-05-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" Метил 2,3,8-триоксо-4-фенилтетрагидро-6Н-пиразоло[1,2-а]пирроло[2,3-c]пиразол-9а(1Н)-карбоксилаты
EP4422621A4 (en) * 2021-10-27 2025-08-27 Merck Sharp & Dohme Llc SPIROTRICYCLIC RIPK1 INHIBITORS AND METHODS OF USE THEREOF

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054291A (pt) 1963-02-26
GB1124982A (en) * 1965-02-09 1968-08-21 Lepetit Spa Diazabicyclo octanes and derivatives thereof
CH529153A (fr) 1969-10-27 1972-10-15 Lepetit Spa Procédé de préparation de pyrazolo (1,2-b) phtalazine-1,5 (10H)-diones
US5358924A (en) * 1991-03-21 1994-10-25 Bayer Aktiengesellschaft 3-hydroxy-4-aryl-5-oxo-pyrozoline derivatives, compositions and use
DK0640086T3 (da) * 1992-05-15 1999-12-06 Merrell Pharma Inc Mercaptoacetylamido-pyridazo[1,2-a][1,2]diazepin-derivateranvendelige som enkephalinase- og ACE-inhibitorer
GB9303993D0 (en) * 1993-02-26 1993-04-14 Fujisawa Pharmaceutical Co New heterocyclic derivatives
CN1272324C (zh) * 1999-09-07 2006-08-30 辛根塔参与股份公司 新颖的除草剂
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

Also Published As

Publication number Publication date
NZ531122A (en) 2005-09-30
CN1250551C (zh) 2006-04-12
CN1257905C (zh) 2006-05-31
EP1427732A1 (en) 2004-06-16
MXPA04002570A (es) 2004-05-31
CN1556811A (zh) 2004-12-22
KR100656126B1 (ko) 2006-12-12
PL370415A1 (en) 2005-05-30
AU2002327690B2 (en) 2006-07-20
WO2003024970A1 (en) 2003-03-27
MA27066A1 (fr) 2004-12-20
JP2005504081A (ja) 2005-02-10
ZA200401260B (en) 2004-08-30
EP1427732B1 (en) 2006-07-12
EP1427727B1 (en) 2005-01-26
PT1427732E (pt) 2006-12-29
ATE287887T1 (de) 2005-02-15
EG24363A (en) 2009-03-04
BR0212716A (pt) 2004-08-03
SK1492004A3 (en) 2004-11-03
BR0212905A (pt) 2004-10-13
HUP0402500A2 (hu) 2005-03-29
KR100623879B1 (ko) 2006-09-19
ES2282459T3 (es) 2007-10-16
DK1427728T3 (da) 2007-07-09
CZ2004361A3 (cs) 2004-07-14
ES2268154T3 (es) 2007-03-16
PE20030474A1 (es) 2003-07-22
US6821971B2 (en) 2004-11-23
PT1427728E (pt) 2007-05-31
ZA200401403B (en) 2004-08-30
HUP0402378A2 (hu) 2005-02-28
KR20060036125A (ko) 2006-04-27
RU2004111805A (ru) 2005-04-10
RU2004111806A (ru) 2005-03-27
DE60218704T2 (de) 2007-11-08
SK1502004A3 (en) 2004-09-08
HUP0402500A3 (en) 2008-10-28
HK1071366A1 (en) 2005-07-15
IL160742A0 (en) 2004-08-31
EP1427727A1 (en) 2004-06-16
RU2299885C2 (ru) 2007-05-27
CN1555375A (zh) 2004-12-15
RU2272040C2 (ru) 2006-03-20
CY1106398T1 (el) 2011-10-12
KR20040035837A (ko) 2004-04-29
KR20040035836A (ko) 2004-04-29
AU2002334641B2 (en) 2007-03-29
ATE356126T1 (de) 2007-03-15
DK1427732T3 (da) 2006-10-30
CN1555379A (zh) 2004-12-15
DE60202782T2 (de) 2006-01-19
CA2461072A1 (en) 2003-03-27
AR037502A1 (es) 2004-11-17
CO5560590A2 (es) 2005-09-30
PL370362A1 (en) 2005-05-16
AR037145A1 (es) 2004-10-27
NO20041594L (no) 2004-06-21
CO5560589A2 (es) 2005-09-30
ZA200401402B (en) 2004-08-27
CO5560579A2 (es) 2005-09-30
WO2003024973A1 (en) 2003-03-27
WO2003024971A1 (en) 2003-03-27
MA27064A1 (fr) 2004-12-20
NO20041605L (no) 2004-06-21
KR20040035835A (ko) 2004-04-29
BR0212673A (pt) 2004-08-24
US6566357B1 (en) 2003-05-20
SA03230529B1 (ar) 2008-06-21
DE60213108T2 (de) 2007-02-08
DE60213108D1 (de) 2006-08-24
DE60218704D1 (de) 2007-04-19
CZ2004358A3 (cs) 2004-07-14
HUP0402378A3 (en) 2008-10-28
PE20030430A1 (es) 2003-06-24
JP2005504083A (ja) 2005-02-10
RU2004111803A (ru) 2005-10-10
MY129329A (en) 2007-03-30
CA2461073A1 (en) 2003-03-27
EP1427728A1 (en) 2004-06-16
MY129069A (en) 2007-03-30
CZ2004345A3 (cs) 2004-06-16
JP2005504082A (ja) 2005-02-10
RU2278864C2 (ru) 2006-06-27
CA2461071A1 (en) 2003-03-27
MXPA04002574A (es) 2004-06-18
IL160682A0 (en) 2004-08-31
ES2237691T3 (es) 2005-08-01
AR037237A1 (es) 2004-11-03
CN1249066C (zh) 2006-04-05
MA27065A1 (fr) 2004-12-20
DE60202782D1 (de) 2005-03-03
US20030105084A1 (en) 2003-06-05
ATE332901T1 (de) 2006-08-15
NZ531063A (en) 2007-08-31
PT1427727E (pt) 2005-06-30
SK1482004A3 (en) 2004-08-03
PE20030446A1 (es) 2003-07-21
IL160741A0 (en) 2004-08-31
EP1427728B1 (en) 2007-03-07
PL370351A1 (en) 2005-05-16
NZ531123A (en) 2006-08-31
HK1071565A1 (en) 2005-07-22
HUP0500752A2 (en) 2006-01-30
MXPA04002569A (es) 2004-05-31

Similar Documents

Publication Publication Date Title
EP1395240A4 (en) MODIFYING THE DELAYED RELEASE PROFILE
EG24413A (en) Compound which inhibit the release of inflammatory cytokines
GB0119467D0 (en) Novel compound
EP1402223A4 (en) MOUTH BRAKE
GB0218157D0 (en) Compositions for controlled release
IL162388A0 (en) Substituted phenyl derivatives
GB0114198D0 (en) Herbicidal composition
PL366891A1 (en) Herbicidal composition
IL162485A0 (en) Compounds for the treatment of inflammatory disorders
IS6889A (is) Ímídazólýl afleiður sem tálmar kortíkótrópíns losunarþátts
GB0114719D0 (en) Compound
GB0118517D0 (en) Compound
PL383682A1 (pl) Sposób hydrocyjanowania olefinowo nienasyconego związku
HUP0303245A3 (en) Herbicidal composition
PL368002A1 (en) Herbicidal composition
ZA200500741B (en) Compositions against inflammatory processes
EP1415655A4 (en) IMMUNOTHERAPY FOR PEOPLE
PL368810A1 (en) Herbicidal composition
GB0129121D0 (en) Compound
PL369829A1 (en) Substituted 1h-quinolin-2-one compounds
GB0127923D0 (en) Compound
AU2002359382A1 (en) Quick release assembly
IL161178A0 (en) MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
PL368553A1 (en) Solid composition
TW581334U (en) The compound structure of terminal